(MENAFN- GlobeNewsWire - Nasdaq) Growing Demand for Precision Bioprocessing and Protein Research Fuels Global Expansion.Pune, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Cell Lysis and Disruption Market Size & Growth Analysis
“SNS Insider reported that global Cell Lysis and Disruption Market was valued at USD 5.21 billion in 2023 and is projected to reach USD 10.92 billion by 2032, growing at a CAGR of 8.61% during the forecast period of 2024–2032.”
This strong growth is driven by the expanding biopharmaceutical industry, rising demand for recombinant proteins, and the growing number of cell-based research studies. Cell lysis, the process of breaking open cells to extract proteins, nucleic acids, or other biomolecules remains a critical step in drug discovery, molecular diagnostics, and vaccine development.
Download Sample Report of Cell Lysis and Disruption Market @
Cell Lysis and Disruption Market Overview
Cell lysis and disruption are fundamental steps in biotechnology and pharmaceutical workflows, allowing scientists to access intracellular components such as proteins, nucleic acids, and metabolites. These techniques are essential for a broad range of applications, including drug discovery, vaccine development, molecular diagnostics, and commercial biomanufacturing.
In the United States, market momentum is being driven by a combination of factors: a strong pharmaceutical pipeline, increased federal and private funding for life sciences, and the accelerating adoption of cell and gene therapy manufacturing. Automated and high-throughput lysis systems are gaining traction, helping laboratories improve reproducibility, reduce manual labor, and optimize sample preparation efficiency.
Major Companies in the Cell Lysis and Disruption Market Include:
Thermo Fisher Scientific Inc. Merck KGaA Bio-Rad Laboratories Inc. F. Hoffmann-La Roche Ltd. QIAGEN N.V. Danaher Corporation Miltenyi Biotec Claremont BioSolutions LLC IDEX Corporation Parr Instrument Company Covaris LLC Cell Signaling Technology Inc. Qsonica LLC Becton Dickinson and Company (BD) BioVision Inc. Microfluidics International Corporation Norgen Biotek Corp. NZYTech Lda PromoCell GmbH STEMCELL Technologies Inc.
Cell Lysis and Disruption Market Segment Insights
By Technique
Reagent-based techniques dominated the market in 2023, capturing 76.25% of total revenue. Their popularity is rooted in their scalability, ease of use, and cost-effectiveness. Optimized buffer systems and customized reagent formulations are widely used in protein extraction, nucleic acid isolation, and high-throughput research workflows, making them the preferred solution for academic and industrial laboratories.
By Product
Reagents and consumables led the market with a 65.41% share in 2023. Their recurring use and compatibility with diverse research applications make them indispensable in molecular biology, proteomics, and drug discovery. Growth in this segment is supported by the availability of enzyme-based and environmentally friendly formulations that enhance efficiency and sustainability.
By Cell Type
Mammalian cells accounted for 46.30% of the market in 2023, reflecting their central role in biologics production, vaccine development, cancer research, and gene therapy. Meanwhile, the yeast, algae, and fungi segment is expected to post the fastest growth rate, driven by rising demand for microbial expression systems in biofuels, industrial biotechnology, and synthetic biology applications.
Regional Outlook
North America remains the leading market, holding a 38.10% share in 2023. Its position is supported by advanced pharmaceutical and biotechnology industries, a favorable regulatory environment, and significant investment in R&D. The U.S. is at the core of this growth, with increased adoption of automated and single-use lysis systems in both research and manufacturing environments.
Asia Pacific is projected to be the fastest-growing region, with a CAGR of 9.26% during the forecast period. This growth is fueled by expanding biotech investments, increased pharmaceutical production, and government-backed life science initiatives in countries such as China, India, and Japan. The region also benefits from cost advantages and a rising number of contract research organizations (CROs), positioning it as a key hub for future bioprocessing advancements.
Need Any Customization Research on Cell Lysis and Disruption Market, Enquire Now:
Recent Developments
Thermo Fisher Scientific launched a next-generation automated lysis platform in Q1 2025, designed to increase throughput for bioprocessing labs. Danaher Corporation (Beckman Coulter Life Sciences) introduced a microfluidics-based cell disruption device with reduced shear force, preserving protein functionality. Merck KGaA expanded its consumables portfolio with environmentally sustainable lysis buffers in late 2024. Sartorius AG announced a strategic partnership with a U.S. biotech company to co-develop single-use lysis systems for GMP manufacturing. Qiagen upgraded its nucleic acid extraction kits with improved yields for small sample volumes, benefiting precision oncology research.
Cell Lysis and Disruption Market Trends and Statistics
Over USD 2.5 billion in federal and private investments flowed into bioprocessing technology R&D in 2023, a 15% increase from 2021. Automated cell disruption systems are expected to reduce overall sample preparation time by 30–40% by 2027. Demand for single-use bioprocessing solutions in lysis workflows is projected to grow at 10.2% CAGR over the next decade. Protein therapeutics now represent more than 40% of all drugs in the global pipeline, reinforcing long-term demand for cell lysis systems. Cloud-based bioinformatics integration with lysis workflows is projected to reach 65% adoption by 2030.
Exclusive Sections of the Report (The USPs)
This market analysis provides critical insights for stakeholders seeking to understand adoption drivers, competitive positioning, and future opportunities. Key features include:
Disease incidence and prevalence metrics to gauge demand for cell lysis technologies in cancer, infectious disease, and genetic research. Research and diagnostic adoption metrics that assess utilization rates across academia, biopharma, and clinical labs. Healthcare spending benchmarks highlighting regional investment patterns in life sciences and precision medicine. Regulatory and compliance insights to monitor safety standards and bioprocessing quality requirements. Technological advancement metrics tracking innovations in mechanical, chemical, enzymatic, and high-pressure disruption approaches. Supply chain and production efficiency data for evaluating reagent availability, manufacturing trends, and capacity utilization. Competitive landscape analysis outlining product portfolios, partnerships, and regional strategies of leading market players.
Get the Full Report of Cell Lysis and Disruption Market Report (Single-User License):
Cell Lysis and Disruption Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | US$ 5.21 Billion |
| Market Size by 2032 | US$ 10.92 Billion |
| CAGR | CAGR of 8.61 % From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | . By Technique (Reagent-based, Physical Disruption)
. By Product (Instruments, Reagents & Consumables)
. By Cell Type (Mammalian Cells, Bacterial Cells, Yeast/Algae/Fungi, Plant Cells)
. By Application (Protein Isolation, Downstream Processing, Cell Organelle Isolation, Nucleic Acid Isolation)
. By End-use (Academic And Research Institutes, Hospitals And Diagnostic Labs, Cell Banks, Pharmaceutical And Biotechnology Companies) |
| Regional Analysis | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
3D Cell Culture Market Size Projected to Surpass Reaching USD 4.0 Billion by 2032 with 12.4% CAGR
Cell & Gene Therapy Manufacturing Services Market Size Worth US$ 70.7 Billion by 2032
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: ...
Comments
No comment